BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 8922322)

  • 1. Angiographic demonstration of inhibition of methyl-ergonovine-induced coronary vasospasm in a patient with sudden death.
    Cutler D; Ghazzal Z; Deam G; Walter P
    Cathet Cardiovasc Diagn; 1996 Oct; 39(2):181-4. PubMed ID: 8922322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Coronary vasospasm: a cause of sudden death. Case report of reversible heart arrest with spontaneous coronary spasm documented by angiography].
    Guénot O; Pellet J; Terraube P; Grosclaude G; Couche L; Legrand M; Arnaud-Crozat E
    Arch Mal Coeur Vaiss; 1990 Nov; 83(12):1859-62. PubMed ID: 2125197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The local and systemic effects of intracoronary ergonovine in patients with normal and nonspastic coronary arteries. A comparison with the intravenous ergonovine test].
    Fournier JA; Cortacero JA; Hernández Aparicio MC; Granado C; Vallejo J
    Rev Esp Cardiol; 1991; 44(6):383-8. PubMed ID: 1924954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of ergotamine-ergic pharmacologic stress echocardiography for vasospasm testing in the echo lab: 14 year experience on 478 tests in 464 patients.
    Djordjevic-Dikic A; Varga A; Rodriguez O; Morelos M; Sicari R; Del Negro B; Morales MA; Carpeggiani C; Picano E
    Cardiologia; 1999 Oct; 44(10):901-6. PubMed ID: 10630049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Coronary accelerated arteriosclerosis and vasospasm in the transplanted heart].
    Genoud JL; Delahaye F; Boissonnat P; Ninet J; Loire R; André-Fouët X; Delaye J
    Arch Mal Coeur Vaiss; 1992 Sep; 85(9):1357-60. PubMed ID: 1290401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coronary vasoreactivity to ergonovine after angioplasty: difference between the infarct-related coronary artery and the noninfarct-related coronary artery.
    Yoshitomi Y; Kojima S; Sugi T; Matsumoto Y; Yano M; Kuramochi M
    Coron Artery Dis; 1998; 9(2-3):105-11. PubMed ID: 9647411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of adjunctive intracoronary administration of acetylcholine following intravenous infusion of ergonovine to provoke coronary artery spasm.
    Goto A; Ito S; Kondo H; Nomura Y; Yasue N; Suzumura H; Takeda Y; Tomimoto S; Yamada Y; Horio T; Suzuki S; Fukutomi T; Itoh M
    J Cardiol; 1999 Dec; 34(6):309-16. PubMed ID: 10642927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ergonovine test in angina with normal coronary arteries. Is it worth doing it?
    Coma-Canella I; Castano S; Macías A; Calabuig J; Artaiz M
    Int J Cardiol; 2006 Feb; 107(2):200-6. PubMed ID: 16412797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Usefulness and risks of the ergonovine maleate test in cardiology].
    Albanese C; Rea A
    Recenti Prog Med; 1981 Sep; 71(3):331-3. PubMed ID: 7034085
    [No Abstract]   [Full Text] [Related]  

  • 10. [Coronary artery spasm as a rare cause of sudden heart arrest].
    Schuchert A; Kuck KH; Bleifeld W
    Z Kardiol; 1989 Oct; 78(10):683-7. PubMed ID: 2588757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diffuse three-vessel coronary artery spasm.
    Han SH; Koh KK; Oh KJ; Shin EK
    Int J Cardiol; 2005 Jun; 102(1):161-4. PubMed ID: 15939118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prinzmetal's variant angina and coronary vasospasm].
    Bassán J
    Rev Med Panama; 1982 May; 7(2):77-87. PubMed ID: 7100521
    [No Abstract]   [Full Text] [Related]  

  • 13. Provocative testing for coronary artery spasm: specific methodology.
    Goldberg S
    Cardiovasc Clin; 1983; 14(1):99-109. PubMed ID: 6413062
    [No Abstract]   [Full Text] [Related]  

  • 14. Provocation of coronary artery spasm.
    Schroeder JS; Ginsburg R
    Cardiovasc Clin; 1983; 13(3):371-83. PubMed ID: 6411340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Coronary artery spasm provocation test with ergometrin. Apropos of 45 cases].
    Ghannem R; Alami M; Aouad A; Hajji L; Merzouk A; el Heitem N; Benmimoun EG; Benomar M
    Tunis Med; 1996 Dec; 74(12):557-62. PubMed ID: 9506059
    [No Abstract]   [Full Text] [Related]  

  • 16. Ergonovine-testing-directed therapy and long-term outcome of sudden-death survivors with no apparent heart disease.
    Ritchie ME; Hattemer C; Lenihan D
    Cardiology; 1998; 89(1):76-8. PubMed ID: 9452162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sudden cardiac death and coronary spasm: a case report.
    Sorbera C; Hadid A; Cohen M
    Heart Dis; 1999; 1(3):136-7. PubMed ID: 11720616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cardiac events in vasospastic angina: site and morphology of coronary artery spasm is related to the long-term prognosis of vasospastic angina].
    Mori F; Uchida T; Byun T; Tanino S; Imamura K; Oomori H; Nagashima M; Enta K; Tanaka M; Kasahara S; Hirosawa K
    J Cardiol; 1999 Apr; 33(4):191-9. PubMed ID: 10225201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relation of high-sensitivity C-reactive protein level with coronary vasospastic angina pectoris in patients without hemodynamically significant coronary artery disease.
    Hung MJ; Cherng WJ; Yang NI; Cheng CW; Li LF
    Am J Cardiol; 2005 Dec; 96(11):1484-90. PubMed ID: 16310426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coronary vasospasm and aborted sudden death treated with an implantable defibrillator and stenting.
    Fiocca L; Di Biasi M; Bruno N; Ciuffreda M; Zumbo F; Mangiameli D; Montenero AS
    Ital Heart J; 2002 Apr; 3(4):270-3. PubMed ID: 12025377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.